10-Q/A: WK Kellogg Co Restates Q1, Cites Material Weakness

WK Kellogg Co has restated its first-quarter 2025 financial results and prior periods due to an inventory accounting error, revealing a material weakness in internal controls.

Summary

• WK Kellogg Co restated its unaudited consolidated financial statements for the quarter ended March 29, 2025, and prior periods, including fiscal year 2024 and its preceding quarters.
• The restatement was due to an error that understated Inventory, overstated Cost of Goods Sold, and impacted Income Tax, stemming from double-counted manufacturing expenses post-spin-off from Kellanova.
• The error had no cash impact and did not affect manufacturing operations.
• Management concluded that disclosure controls and procedures were not effective as of March 29, 2025, due to a material weakness in internal control over financial reporting.
• Net sales for Q1 2025 decreased by 6.2% to $663 million from $707 million in Q1 2024.
• Net income for Q1 2025 decreased by 38.2% to $21 million from $34 million in Q1 2024.
• Operating profit for Q1 2025 decreased by 50% to $24 million from $48 million in Q1 2024.
• Adjusted EBITDA saw a slight decrease of 1.3% to $75 million in Q1 2025 from $76 million in Q1 2024.
• The company is progressing with its supply chain modernization restructuring plan, including closing the Omaha, Nebraska plant by end of 2026 and scaling back the Memphis, Tennessee facility from late 2025.
• Q1 2025 restructuring charges totaled $14 million.
• Free cash flow was negative $(69) million for Q1 2025, compared to $1 million in Q1 2024, primarily due to increased capital spending on the restructuring project.

Sentiment

Score: 3

Explanation: The restatement of financial statements due to a material weakness in internal controls is a severe negative, indicating fundamental issues in financial reporting reliability. While adjusted gross margins improved, the significant decline in net sales, operating profit, and net income, coupled with negative free cash flow, points to operational challenges and a difficult market environment. The strategic restructuring is a long-term positive, but its immediate cash drain and the underlying control issues create substantial uncertainty.

Positives

• Adjusted gross margin increased by 50 basis points to 30.1% in Q1 2025, driven by increased operational effectiveness within the supply chain.
• The identified accounting error had no cash impact and no impact on manufacturing operations.
• The supply chain modernization restructuring project is progressing on schedule.
• Management believes current liquidity (cash, operating activities, borrowing capacity) is adequate for current and long-term obligations, capital expenditures, and investment opportunities.

Negatives

• The company identified a material weakness in its internal control over financial reporting, leading to the restatement of financial statements for multiple periods.
• Net sales decreased by 6.2% in Q1 2025 compared to the prior year, with organic net sales declining by 5.6% due to an 8.6% volume decrease.
• Net income significantly decreased by 38.2% in Q1 2025 compared to the prior year.
• Operating profit decreased by 50% in Q1 2025 compared to the prior year.
• Free cash flow was negative $(69) million in Q1 2025, a significant decline from $1 million in Q1 2024, primarily due to increased capital spending.
• Cash and cash equivalents decreased from $47 million at December 28, 2024, to $27 million at March 29, 2025.
• Increased indebtedness with an additional $50 million borrowed under the Credit Facility in Q1 2025.

Risks

• Uncertain and rapidly evolving global trade environment, including potential new or increased tariffs from the U.S. government, which could increase cost of goods sold.
• Macroeconomic uncertainty, including the risk of recession, high interest rates, and inflationary pressures, potentially exacerbated by geopolitical instability (e.g., war in Ukraine, Middle East conflict) affecting commodity costs.
• Regulatory changes, such as the FDA's plan to eliminate FD&C colors, which could increase manufacturing costs and require additional capital expenditures for new equipment and facility reconfiguration.
• Intense competition in the concentrated cereal product category, impacting brand recognition, taste, nutritional value, price, promotion, innovation, shelf space, and customer service.
• Challenging retail environment with further consolidation, requiring strong marketing, product innovation, and high service levels.
• Potential for unanticipated costs or expenditures related to the supply chain modernization restructuring plan.
• Impact of the restatements on the company's reputation and relationships with investors, suppliers, customers, and other parties.
• Inability to remediate the material weakness in internal control over financial reporting in a timely manner.
• Decline in demand for ready-to-eat cereals.
• Supply chain disruptions and increases in costs and/or shortages of raw materials, labor, fuels, and utilities.
• Failure to achieve targeted cost savings and efficiencies from cost reduction initiatives or expected benefits from supply chain modernization.
• Inability to obtain sufficient capital to grow the business.
• Increases in post-retirement benefit-related costs and funding requirements due to market volatility or interest rate changes.

Future Outlook

The company anticipates potentially increasing indebtedness in the near term to fund important capital projects, with a subsequent plan to reduce indebtedness to enhance financial flexibility and shareholder value. It expects to reclassify approximately $1 million of net deferred gains from AOCI to interest expense within the next 12 months. The company is evaluating the impact of new accounting standards for income tax disclosures (effective FY2026) and disaggregation of income statement expenses (effective FY2028).

Management Comments

• "Management believes that our cash balances and funds provided by operating activities, along with borrowing capacity under the Credit Facility and access to capital markets, taken as a whole, provide (i) adequate liquidity to meet all of our current and long-term obligations when due, including third-party debt that was incurred in connection with the Spin-Off, (ii) adequate liquidity to fund capital expenditures primarily utilized in manufacturing our products, and (iii) flexibility to meet investment opportunities that may arise."
• "We plan to utilize such flexibility to drive an investment philosophy that balances capital investments in areas such as supply chain optimization, cost-saving projects and new capabilities, with the ability to further increase shareowner value through a combination of debt reduction, return of capital to our shareowners in the form of dividends as well as potential acquisitions."
• "In the near term we may increase our indebtedness to fund important capital projects. Thereafter, however, we anticipate being able to reduce indebtedness as a way to increase our financial flexibility and enhance shareowner value."
• "Currently, this project [supply chain modernization] is progressing on schedule."

Industry Context

The company operates in a highly competitive North American cereal market, facing intense competition from both branded and private label products. The retail environment is consolidating, requiring strong marketing and innovation. Broader macroeconomic factors like inflation, high interest rates, and geopolitical instability (e.g., Ukraine war, Middle East conflict) are impacting commodity costs, though the company has largely offset these through productivity and pricing. Regulatory changes, such as the FDA's push to eliminate FD&C colors, will require industry-wide adaptation and investment.

Comparison to Industry Standards

• The filing does not provide specific comparable companies or projects for direct benchmarking.
• The company's reported gross margin of 29.2% and adjusted gross margin of 30.1% reflect operational effectiveness within its supply chain, which is a positive in a challenging inflationary environment.
• The significant decline in net sales volume (-8.6%) due to price elasticity suggests that the company's pricing strategies, while improving gross margin, may be impacting market share or consumer demand more severely than some competitors who might be absorbing more cost or offering more competitive pricing.
• The material weakness in internal controls and subsequent restatement are significant deviations from expected industry standards for financial reporting integrity, potentially impacting investor confidence compared to peers with robust controls.

Corporate Governance

Legal Proceedings

• The company is subject to various legal proceedings, claims, and governmental inspections in the ordinary course of business, including general commercial, regulatory, antitrust, product liability, environmental, intellectual property, workers compensation, and employment matters.
• Management does not expect any of the pending claims or legal proceedings to have a material impact on the consolidated financial statements based on current information.

Related Party Transactions

• The company entered into several agreements with Kellanova (formerly Kellogg Company) following the spin-off, including a Separation and Distribution Agreement, Employee Matters Agreement, Supply Agreement, Master Ownership and License Agreements, Tax Matters Agreement, and Transition Services Agreement.
• During Q1 2025, the company entered into a lease agreement with an unrelated third party for a distribution center previously subleased directly from Kellanova, which was managed under a transition services agreement.

Stakeholder Impact

• Shareholders: Impacted by the restatement of financial results, material weakness in internal controls, and declining net income and EPS. The dividend payment provides some return, but negative free cash flow and potential increased indebtedness could be concerns.
• Employees: Impacted by the supply chain modernization plan, which includes plant closures (Omaha) and production scale-backs (Memphis), leading to phased reductions and severance benefits for impacted employees.
• Customers: May be affected by changes in supply chain and manufacturing network, though the company aims for increased operational effectiveness. Pricing strategies have led to volume declines, potentially impacting customer demand.
• Suppliers: Those participating in supplier finance programs have flexibility, but the company's right to offset balances is restricted for sold obligations.
• Regulatory Authorities: The SEC is directly involved with the restatement and material weakness disclosure. The FDA's potential new regulations on FD&C colors will require compliance and investment.

Next Steps

• Continue implementing the supply chain modernization plan, including phased production reduction at Omaha (late 2025) and Memphis (late 2025), with full Omaha closure by end of 2026.
• Incurring remaining restructuring charges through 2027.
• Remediate the material weakness in internal control over financial reporting by designing and implementing new controls over Inventory and Cost of Goods Sold.
• Evaluate the impact and adopt new accounting standards for income tax disclosures (effective FY2026) and disaggregation of income statement expenses (effective FY2028).
• Potentially increase indebtedness in the near term to fund capital projects.
• Reduce indebtedness after funding capital projects to increase financial flexibility and enhance shareholder value.
• Pay a dividend of $0.165 per share on June 13, 2025.

Key Dates

Recommendation

The restatement of financial statements due to a material weakness in internal controls is a severe red flag, indicating unreliable financial reporting. This fundamental issue, combined with significant declines in net sales, operating profit, and net income, and negative free cash flow, points to substantial operational and financial challenges. While the supply chain restructuring is a necessary long-term strategic move, its immediate cash drain and the underlying control deficiencies create high uncertainty and risk. The company's inability to maintain sales volume despite pricing initiatives suggests a weakening competitive position. Until the material weakness is remediated and financial performance stabilizes with clear signs of recovery, the stock carries significant downside risk.

Keywords

WK Kellogg Co, KLG, SEC Filing, 10-Q/A, Financial Restatement, Material Weakness, Internal Controls, Cereal Industry, Supply Chain Modernization, Financial Performance, Quarterly Report, Earnings, Inventory Accounting, Corporate Governance, Risk Management, Consumer Staples, Food Manufacturing